Hoffman William's Form 4/A amendment
AmendedInari Medical, Inc. (NARI) · filed Feb 9, 2022
- Accession no.
- 0001562180-22-001311
- Filed
- Feb 9, 2022, 7:52 PM ET
- Trade date
- Jan 4, 2022
- Filing delay
- 36 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jan 6, 2022
This filing lists 1 non-derivative transaction and 1 derivative transaction. It carries over 7 transactions from the original filing that it did not restate. Open-market sales total $2.82M. It was filed 36 days after the trade.
This amendment restates part of 0001562180-22-000326 (filed Jan 6, 2022). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman WilliamCIK 0001304099 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 | Common Stock | MOption exerciseAcquired | +28,249 | $0.428 | +$12,090.57 | 538,618 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 | Common Stock | MOption exerciseDisposed | −28,249 | $0.00 | $0 | 230,467 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001562180-22-000326 (filed Jan 6, 2022).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 | Common Stock | SSaleDisposed | −11,158 | $92.53F2 | −$1,032,449.74 | 468,663 | Direct | |
| Jan 4, 2022 | Common Stock | SSaleDisposed | −6,511 | $93.55F3 | −$609,104.05 | 462,152 | Direct | |
| Jan 4, 2022 | Common Stock | SSaleDisposed | −5,414 | $94.76F4 | −$513,030.64 | 456,738 | Direct | |
| Jan 4, 2022 | Common Stock | SSaleDisposed | −3,566 | $95.27F5 | −$339,732.82 | 453,172 | Direct | |
| Jan 4, 2022 | Common Stock | SSaleDisposed | −500 | $96.65F6 | −$48,325 | 452,672 | Direct | |
| Jan 4, 2022 | Common Stock | SSaleDisposed | −2,651 | $97.76F7 | −$259,161.76 | 450,021 | Direct | |
| Jan 4, 2022 | Common Stock | SSaleDisposed | −200 | $98.54 | −$19,708 | 449,821 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F2
This transaction was executed in multiple trades at prices ranging from $92.06 to $93.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $93.11 to $94.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $94.11 to $95.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $95.11 to $95.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $96.12 to $97.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $97.54 to $98.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2021.
- F2
Option vested with respect to 25% of the underline shares on May 3, 2019 and vest with respect to the remaining shares in 36 equal monthly installments thereafter.
Remarks
This amended Form 4 is being filed solely to show that the shares acquired were sold as reported in previously filed Form 4s.